Rigel Pharmaceuticals | RIGL - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.61B 777M 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Celldex Therapeutics USD -80.62M 3.81M 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Intrexon USD -60.84M 26.62M 2024-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
MacroGenics USD -33.44M 21.34M 2026-03
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Pfizer USD 667M 4.32B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Rigel Pharmaceuticals USD 14.06M 13.61M 2024-09
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Veracyte USD 23.96M 4.88M 2026-06